| Authors: |
Ahmed A; Translational Immunotherapy (D240), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.; BioQuant, Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Klotz R; General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany., Köhler S; Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany., Giese N; General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany., Hackert T; General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany., Springfeld C; Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany., Jäger D; Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.; Applied Tumor Immunity Clinical Cooperation Unit (D120), National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany., Halama N; Translational Immunotherapy (D240), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.; BioQuant, Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Helmholtz Institute for Translational Oncology Mainz (HI-TRON), Mainz, Germany. |
